无症状高尿酸血症患者及痛风患者超声痛风征象与血清细胞因子和微小RNA水平的相关性:从基础到临床
研究纳入30例无症状高尿酸血症、31例血尿酸正常对照和30例痛风患者,均行肌肉骨骼超声并检测血清细胞因子及miR水平。无症状高尿酸血症与痛风患者的滑膜炎和双轨征频率相似且均高于对照,血清IL-6、IL-8及miR-155水平亦相似且均高于对照。有尿酸盐沉积超声征象者的IL-6、IL-8和miR-155水平高于无沉积征象者。
要点
- 无症状高尿酸血症者超声滑膜炎和双轨征频率与痛风患者相似,均高于血尿酸正常对照。
- 无症状高尿酸血症者血清IL-6、IL-8及miR-155水平与痛风患者相似,均高于对照。
- 有尿酸盐沉积超声征象者IL-6、IL-8和miR-155水平高于无沉积征象者。
核心结论
- 在慢性无症状高尿酸血症个体中,超声发现的滑膜炎和双轨征可能代表单钠尿酸盐晶体成核的亚临床表现,能够触发炎症通路(IL-6和IL-8)和细胞间通讯机制(miR-155),与痛风患者中所见相似。
研究设计与样本
- 纳入30例无症状高尿酸血症个体、31例血尿酸正常对照和30例痛风患者,所有参与者均接受肌肉骨骼超声检查并测量血清细胞因子及miR水平。
主要发现
- 无症状高尿酸血症组与痛风组的超声滑膜炎频率分别为67%和77%,双轨征频率均为27%,两组均高于对照组(滑膜炎45%,双轨征0%)。
- 无症状高尿酸血症组血清IL-6和IL-8水平(均值±标准差分别为69.7±73.4和18.5±25.6 pg/ml)与痛风组(75.8±47.6和24.4±31.7 pg/ml)相似,且均高于对照组(28.2±17.6和7.4±6.0 pg/ml)。
- 无症状高尿酸血症组、痛风组和对照组的miR-155水平(均值±标准差分别为0.22±0.18、0.20±0.14和0.08±0.04)呈现相似的分布。
- 有尿酸盐沉积超声征象者(无论临床诊断)的IL-6水平为257.2 pg/ml,高于无沉积征象者的47.0 pg/ml(P=0.005)。
- 有尿酸盐沉积超声征象者的IL-8水平为73.2 pg/ml,高于无沉积征象者的12.0 pg/ml(P=0.026);miR-155水平为0.21,高于无沉积征象者的0.16(P=0.015)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To assess potential associations among serum cytokines and microRNA (miR) levels with ultrasound (US) findings suggestive of urate deposits in chronic asymptomatic hyperuricemia and gout. METHODS: All participants underwent musculoskeletal US and measurements of serum interleukin-1β (IL-1β), IL-2, IL-4, IL-5, IL-6, IL-8, IL-10, IL-12, IL-13, interferon-γ, tumor necrosis factor, monocyte chemoattractant protein 1, and epithelial neutrophil-activating peptide 78, as well as miR-146a, miR-155, and miR-223 levels. RESULTS: Thirty individuals with asymptomatic hyperuricemia, 31 normouricemic controls, and 30 patients with gout were included. The frequency of synovitis and double contour sign using US was similar between asymptomatic hyperuricemia (67% and 27%, respectively) and patients with gout (77% and 27%, respectively), and each had a higher frequency than controls (45% and 0%, respectively). Serum IL-6 and IL-8 levels were similar between patients with asymptomatic hyperuricemia (mean ± SD 69.7 ± 73.4 and 18.5 ± 25.6 pg/ml, respectively) and gout (mean ± SD 75.8 ± 47.6 and 24.4 ± 31.7 pg/ml, respectively), and higher than controls (mean ± SD 28.2 ± 17.6 and 7.4 ± 6.0 pg/ml, respectively). A similar distribution was observed for miR-155 levels in asymptomatic hyperuricemia, patients with gout, and controls (mean ± SD 0.22 ± 0.18, 0.20 ± 0.14, and 0.08 ± 0.04, respectively). Associations between morphostructural abnormalities suggestive of urate deposits (regardless of clinical diagnosis) and serum markers were assessed. Subjects with urate deposits had higher IL-6 (257.2 versus 47.0 pg/ml; P = 0.005), IL-8 (73.2 versus 12.0 pg/ml; P = 0.026), and miR-155 (0.21 versus 0.16; P = 0.015) levels than those without deposition findings. CONCLUSION: In individuals with chronic asymptomatic hyperuricemia, the presence of synovitis and double contour sign by US may represent a subclinical manifestation of monosodium urate crystal nucleation, capable of triggering inflammatory pathways (IL-6 and IL-8) and mechanisms of intercellular communication (miR-155), similar to what is observed in patients with gout.
引用
- Estevez-Garcia IO, Gallegos-Nava S, Vera-Pérez E, et al. Levels of Cytokines and MicroRNAs in Individuals With Asymptomatic Hyperuricemia and Ultrasonographic Findings of Gout: A Bench-to-Bedside Approach. Arthritis Care Res (Hoboken). 2018. PMID: 29457379. doi:10.1002/acr.23549
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。